Edina Cenko Shared STRIVE Trial – Intracoronary Alteplase Shows No Advantage in STEMI
Edina Cenko, Chairperson of ESC Working Group on Coronary Pathophysiology and Microcirculation, posted on LinkedIn:
”The STRIVE trial showed that intracoronary alteplase during primary PCI for STEMI with high thrombus burden did not improve MACE, ST-segment resolution or myocardial blush grade compared with placebo, with a signal toward more ventricular fibrillation.
Once more, no adjunctive strategy has yet succeeded in improving downstream microvascular perfusion after epicardial flow is restored. The search for an effective solution in MVO after STEMI continues.”
Read the study here.
Title: Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator in Primary PCI for ST-Segment Elevation Myocardial Infarction and Large Thrombus Burden: A Randomized Trial
Authors: Shamir R. Mehta, Natalia Pinilla-Echeverri, Denise Tiong, Tanya Kovalova, Tej Sheth, Madhu K. Natarajan, Matthew Sibbald, James L. Velianou, Robert Welsh, Bryan Har, Sanjit S. Jolly, Nicholas Valettas, J.D. Schwalm, Michael Tsang, Rutaba Khatun, Rajibul Mian, Jennifer Cunningham, Eric Ly, Tara McCready, Kevin R. Bainey
Stay updated with Hemostasis Today.
-
Jul 10, 2026, 20:47New Machine Learning Models Improve Prediction of Thrombosis and Bleeding in Cancer – JTH
-
Jul 10, 2026, 20:39Evangelia Petsalaki: New Systems Biology Approach Identifies Biomarkers in Thrombotic APS
-
Jul 10, 2026, 20:29Wolfgang Miesbach: Celebrating Pantep Angchaisuksiri’s Transformative Leadership of the ISTH
-
Jul 10, 2026, 20:17Amy Pantaleo: How Staffing Shortages Are Changing Hemostasis Laboratories
-
Jul 10, 2026, 20:15Gene Nudelman: Early Hemorrhage Control Improves Patient Outcomes
-
Jul 10, 2026, 20:15Lee G.: Can We Transform Dengue Patient Management with Better Coagulation Assessment?
-
Jul 10, 2026, 20:13Shahin Alam: Is Your Coagulant Limiting Your Water Treatment Performance?
-
Jul 10, 2026, 20:12Ali Bozorgi: Our Meta-Analysis on Oral Anticoagulation After AF Ablation Featured in EP Europace
-
Jul 10, 2026, 15:34Joy Celebre: A New Opportunity in Hemostasis Leadership